| 标题 |
[高分] A double-blind placebo-controlled study to evaluate the safety and efficacy of FcRn antagonist ARGX-113 (efgartigimod) in generalized myasthenia gravis
一项评估FcRn拮抗剂ARGX-113(efgartigimod)治疗全身性重症肌无力安全性和有效性的双盲安慰剂对照研究
|
| 网址 |
求助人暂未提供
|
| DOI |
暂未提供,该求助的时间将会延长,查看原因?
|
| 其它 | HOWARD JF, BRIL V, MANTEGAZZA R, et al. A double-blind placebo-controlled study to evaluate the safety and efficacy of FcRn antagonist ARGX-113 (efgartigimod) in generalized myasthenia gravis[J]. Neurology, 2018, 90(24): e2193 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)